| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.09 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.09 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.29 | 0.09 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |